Prajna Guha, PhD
Assistant Professor
Boston University School of Medicine
Dept of Surgery

PhD, St John's University
MS, Northeastern University



Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Guha P, Heatherton KR, O'Connell KP, Alexander IS, Katz SC. Assessing the Future of Solid Tumor Immunotherapy. Biomedicines. 2022 Mar 11; 10(3).View Related Profiles. PMID: 35327456; PMCID: PMC8945484; DOI: 10.3390/biomedicines10030655;
     
  2. Chai LF, Hardaway JC, Heatherton KR, O'Connell KP, LaPorte JP, Guha P, Lopes MC, Rabinowitz BA, Jaroch D, Cox BF, Knight R, Katz SC. Antigen Receptor T Cells (CAR-T) Effectively Control Tumor Growth in a Colorectal Liver Metastasis Model. J Surg Res. 2022 04; 272:37-50.View Related Profiles. PMID: 34929499
     
  3. Guha P, Katz SC. Strategies for manufacturing cell therapy products aligned with patient needs. Methods Cell Biol. 2022; 167:203-226.View Related Profiles. PMID: 35152997
     
  4. DaSilva NA, Barlock BJ, Guha P, Ghosh CC, Trebino CE, Camberg JL, Katz SC, Rowley DC. Proteomic signatures of myeloid derived suppressor cells from liver and lung metastases reveal functional divergence and potential therapeutic targets. Cell Death Discov. 2021 Sep 04; 7(1):232.View Related Profiles. PMID: 34482371; PMCID: PMC8418613; DOI: 10.1038/s41420-021-00621-x;
     
  5. Chai LF, Hardaway JC, Heatherton KR, O'Connell KP, Lopes MC, Rabinowitz BA, Ghosh CC, Guha P, Jaroch D, Cox BF, Katz SC. Regional Delivery of Anti-PD-1 Agent for Colorectal Liver Metastases Improves Therapeutic Index and Anti-Tumor Activity. Vaccines (Basel). 2021 Jul 21; 9(8).View Related Profiles. PMID: 34451932; PMCID: PMC8402391; DOI: 10.3390/vaccines9080807;
     
  6. Guha P, Gardell J, Rabinowitz B, Lopes M, DaSilva NA, Rowley D, Katz SC. Monocytic and granulocytic myeloid-derived suppressor cell plasticity and differentiation are organ-specific. Oncogene. 2021 01; 40(3):693-704.View Related Profiles. PMID: 33230244
     
  7. Katz SC, Moody AE, Guha P, Hardaway JC, Prince E, LaPorte J, Stancu M, Slansky JE, Jordan KR, Schulick RD, Knight R, Saied A, Armenio V, Junghans RP. HITM-SURE: Hepatic immunotherapy for metastases phase Ib anti-CEA CAR-T study utilizing pressure enabled drug delivery. J Immunother Cancer. 2020 08; 8(2).View Related Profiles. PMID: 32843493; PMCID: PMC7449487; DOI: 10.1136/jitc-2020-001097;
     
  8. Katz SC, Hardaway J, Prince E, Guha P, Cunetta M, Moody A, Wang LJ, Armenio V, Espat NJ, Junghans RP. HITM-SIR: phase Ib trial of intraarterial chimeric antigen receptor T-cell therapy and selective internal radiation therapy for CEA+ liver metastases. Cancer Gene Ther. 2020 05; 27(5):341-355.View Related Profiles. PMID: 31155611
     
  9. Guha P, Gardell J, Darpolor J, Cunetta M, Lima M, Miller G, Espat NJ, Junghans RP, Katz SC. STAT3 inhibition induces Bax-dependent apoptosis in liver tumor myeloid-derived suppressor cells. Oncogene. 2019 01; 38(4):533-548.View Related Profiles. PMID: 30158673
     
  10. Guha P, Morgan JW, Mostoslavsky G, Rodrigues NP, Boyd AS. Lack of Immune Response to Differentiated Cells Derived from Syngeneic Induced Pluripotent Stem Cells. Cell Stem Cell. 2017 07 06; 21(1):144-148.View Related Profiles. PMID: 28686864
     
Showing 10 of 14 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 14 publications over 9 distinct years, with a maximum of 4 publications in 2021

YearPublications
20131
20151
20161
20172
20181
20191
20202
20214
20221

Contact for Mentoring:

72 E. Concord Street
Boston MA 02118
Google Map


Guha's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department